Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

UnitedHealth Group Inc (NYSE: UNH) reported Q2 revenues of $71.3 billion, up 15% Y/Y and beating the consensus of $69.5 billion, and adjusted EPS came in at $4.70, surpassing the consensus of $4.43. But net income declined from $7.12 posted a year ago fell due to higher medical expenses, as patients sought medical care they had avoided when the pandemic was raging 12 months earlier.

Analysts Raise Price Target For UnitedHealth After Q2 Earnings Beat Expectations

UnitedHealth reported better-than-expected second-quarter 2021 results, breezing past the Zacks Consensus Estimate for both earnings and revenues.

UnitedHealth's Solid Q2 Earnings Put These ETFs in Focus

UnitedHealth Group (UNH) CEO, Andrew Witty on Q2 2021 Results - Earnings Call Transcript

Taiwan Semiconductor Manufacturing

Investors looking for great companies should scope them out.

2 Blue Chip Stocks Investors Can't Afford to Ignore

UnitedHealth Group's (UNH) second-quarter 2021 results reflect improving revenues resulting in top-line growth at both the business units, partly offset by higher costs.

UnitedHealth (UNH) Beats on Q2 Earnings, Hikes '21 EPS View

UnitedHealth Group Inc (NYSE: UNH) said on Thursday its profit and revenue in the fiscal second quarter topped Wall Street estimates by a significant margin. The health care provider acknowledged that the pandemic was likely to keep weighing on results.

UnitedHealth reported its Q2 financial results: here are the key points

UnitedHealth Group Inc (NYSE: UNH) reports Q2 revenues of $71.3 billion, up 15% Y/Y and beating the consensus of $69.5 billion, reflecting growth across the enterprise. Adjusted EPS came in at $4.70, surpassing the consensus of $4.43.

UnitedHealth Crushes Q2 Earnings, Lifts FY2021 Guidance

Shares of UnitedHealth Group Inc. rose 1.3% in premarket trading Thursday, after the health care provider reported second-quarter profit and revenue that were well above expectations and raised its full-year outlook, even as the company continued to expect COVID-19 to take a bite out of results. Net income fell to $4.27 billion, or $4.46 a share, from $6.64 billion, or $6.91 a share, in the year-ago period.

UnitedHealth stock rises after profit and revenue beats, raised outlook

(Reuters) -UnitedHealth Group Inc reported a 35.7% fall in quarterly profit on Thursday, as a recovery in pandemic-induced slowdown in elective medical care normalized costs for the largest U.S. health insurer.

Health insurer UnitedHealth profit slumps 36% as medical costs normalize

MINNETONKA, Minn.--(BUSINESS WIRE)--Strong and diversified growth continued across UnitedHealth Group (NYSE: UNH) in the second quarter 2021. “The compassion, dedication and ongoing efforts of our 330,000 colleagues to advance peoples' health and health system performance reinforces our confidence in delivering strongly on our strategies for those we serve and continuing to grow well into the future,” said Andrew Witty, chief executive officer of UnitedHealth Group. Based upon first half 2021 p

UnitedHealth Group Reports Second Quarter 2021 Results

Blue chip UnitedHealth Group Inc (NYSE:UNH) is 0.6% lower on the charts this afternoon, last seen at $416.27, with traders most likely practicing caution ahead of earnings.

Blue-Chip Healthcare Stock Suffers Pre-Earnings Pullback

CenterPoint Energy

Alphabet

Mercury General

Walmart

Archer-Daniels-Midland Company

While sentiment in the market couldn't be more bullish, this is exactly why investors may want to consider contrarian stocks to buy. The post 7 of the Best Contrarian Stocks to Buy as Others Get Greedy appeared first on InvestorPlace.

7 of the Best Contrarian Stocks to Buy as Others Get Greedy

UnitedHealth Group (NYSE:UNH) releases its next round of earnings this Thursday, July 15. Here is Benzinga's essential guide to UnitedHealth Group's Q2 earnings report.

Preview: UnitedHealth Group's Earnings

Cintas Corp

Delta Air Lines

Kansas City Southern

Investors should be watching more than just the big banks this week.

5 Earnings Charts to Kick off Earnings Season

Curaleaf Holdings, Inc.

Danaher

GlaxoSmithKline

IQVIA Hlds

Intuitive Surgical

Jazz Pharmaceuticals

LHC Group

Moderna

Invesco S&P 500 Equal Weight Health Care ETF

Vertex Pharmaceuticals

The 2020s could be the decade of healthcare stocks. Here are 10 companies and one ETF to watch not just for the remainder of this year, but well beyond.

11 Best Healthcare Stocks for the Rest of 2021

Caterpillar

Two portfolio holdings at Cash Builder Opportunities have recently raised their dividends.

Caterpillar And UnitedHealth Group: Showing Investors The Money

SPDR Dow Jones Industrial Average ETF

Dow Inc

Goldman Sachs

Intel

Johnson & Johnson

JPMorgan Chase & Co

Coca-Cola

With some blue-chip companies' earnings scheduled for the coming days, investors should closely monitor the movement of the Dow ETF and grab an opportunity that arises from a surge in any of the 30 stocks.

Dow ETF Set to Rise Further as Q2 Earnings Kick Off

Morgan Stanley

U.S. Bancorp

Two of the nation's six biggest banks reported June quarter earnings before Tuesday's opening bell.

Earnings Previews: Morgan Stanley, TSMC, UnitedHealth, US Bancorp

UnitedHealth's (UNH) Q2 revenues are likely to have grown on higher membership. Nevertheless, COVID-related costs and steep expenses due to investment in growth and innovation might have hurt earnings.

UnitedHealth (UNH) to Post Q2 Earnings: What's in the Offing?

Bank of America

Citigroup

Conagra Brands

PepsiCo

Wells Fargo

Markets Await Earnings and Economic Data

Fastenal

Second-quarter earnings season begins this week with results from JPMorgan Chase, Goldman Sachs, Bank of America, Morgan Stanley, Delta Air Lines, TSMC, PepsiCo, UnitedHealth, and many more.

Chase, Delta, Goldman Sachs, PepsiCo, and Other Stocks to Watch This Week

Apple

Palo Alto Networks

A steep market decline would be the perfect opportunity to put your money to work in these highly successful companies.

A Stock Market Crash Is Likely: 3 Winning Stocks to Buy When It Happens

DENTSPLY SIRONA

UnitedHealth Group, Ryman Healthcare, and Dentsply Sirona all had double-digit revenue increases recently. Are any of them worth buying?

Do Big Dividend Increases Make These 3 Medical Stocks Worth Buying?

UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: UnitedHealth Group (UNH) Q2 Earnings Expected to Decline

MINNETONKA, Minn.--(BUSINESS WIRE)--UnitedHealthcare has introduced the use of predictive analytics to help improve well-being, lower costs and drive engagement in clinical-intervention programs by addressing social determinants of health for people in some employer-sponsored benefit plans.1 Building on similar initiatives for UnitedHealthcare Medicare and Medicaid beneficiaries, the new capability adds the use of predictive analytics to help efficiently identify people in need of support relat

News for UnitedHealth Group Stock (UNH)